The infant disease screening system developer has raised $12.8m according to a securities filing, four months after a $10m round backed by BOE and Rex Healthcare.

Baebies, a US-based newborn and paediatric screening technology developer that counts corporates BOE Technology Group and Rex Healthcare as investors, has secured $12.8m in funding, according to a securities filing yesterday.

The participants in the round have not been disclosed but Baebies is targeting a $13m final close for the round, according to the filing. It has now raised $35m in debt and equity financing.

Founded in 2014 to develop technology licensed from genetic sequencing technology producer Illumina, Baebies is…